Houtenbos I - Search Results

1

Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia.

Houtenbos I, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA. Houtenbos I, et al. Haematologica. 2006 Mar;91(3):348-55. Haematologica. 2006. PMID: 16531258 Review.

2

Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation.

Houtenbos I, Westers TM, Stam AG, de Gruijl TD, Scheper RJ, Ossenkoppele GJ, van de Loosdrecht AA. Houtenbos I, et al. Cancer Immunol Immunother. 2003 Jul;52(7):455-62. doi: 10.1007/s00262-003-0389-4. Epub 2003 Apr 11. Cancer Immunol Immunother. 2003. PMID: 12690520 Free PMC article.

3

Quantification of T-cell-mediated apoptosis in heterogeneous leukemia populations using four-color multiparameter flow cytometry.

Westers TM, Houtenbos I, Schuurhuis GJ, Ossenkoppele GJ, van de Loosdrecht AA. Westers TM, et al. Among authors: houtenbos i. Cytometry A. 2005 Jul;66(1):71-7. doi: 10.1002/cyto.a.20146. Cytometry A. 2005. PMID: 15895438 Free article.

4

Employing the immunological synapse in AML: development of leukemic dendritic cells for active specific immunization.

Houtenbos I, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA. Houtenbos I, et al. Immunobiology. 2005;210(2-4):249-57. doi: 10.1016/j.imbio.2005.05.019. Immunobiology. 2005. PMID: 16164032 Review.

5

Principles of dendritic cell-based immunotherapy in myeloid leukemia.

Westers TM, Houtenbos I, van de Loosdrecht AA, Ossenkoppele GJ. Westers TM, et al. Among authors: houtenbos i. Immunobiology. 2006;211(6-8):663-76. doi: 10.1016/j.imbio.2006.06.003. Epub 2006 Jul 21. Immunobiology. 2006. PMID: 16920505 Review.

6

Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia.

Houtenbos I, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA. Houtenbos I, et al. Immunobiology. 2006;211(6-8):677-85. doi: 10.1016/j.imbio.2006.05.013. Epub 2006 Jul 13. Immunobiology. 2006. PMID: 16920506 Review.

7

Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.

Houtenbos I, Westers TM, Dijkhuis A, de Gruijl TD, Ossenkoppele GJ, van de Loosdrecht AA. Houtenbos I, et al. Clin Cancer Res. 2007 Jan 1;13(1):307-15. doi: 10.1158/1078-0432.CCR-06-1430. Epub 2006 Dec 14. Clin Cancer Res. 2007. PMID: 17170077

8

The novel bispecific diabody alphaCD40/alphaCD28 strengthens leukaemic dendritic cell-induced T-cell reactivity.

Houtenbos I, Santegoets S, Westers TM, Waisfisz Q, Kipriyanov S, Denkers F, Scheper RJ, de Gruijl TD, Ossenkoppele GJ, van de Loosdrecht AA. Houtenbos I, et al. Br J Haematol. 2008 Jun;142(2):273-83. doi: 10.1111/j.1365-2141.2008.06990.x. Epub 2008 May 19. Br J Haematol. 2008. PMID: 18492117 Free article.

9

Acute myeloid leukemia in a 23-year-old patient with Beckwith-Wiedemann syndrome.

Houtenbos I, Ossenkoppele GJ. Houtenbos I, et al. Cancer Genet Cytogenet. 2002 Jul 1;136(1):90-1. doi: 10.1016/s0165-4608(02)00528-9. Cancer Genet Cytogenet. 2002. PMID: 12165460

10

Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications.

van de Loosdrecht AA, van den Ancker W, Houtenbos I, Ossenkoppele GJ, Westers TM. van de Loosdrecht AA, et al. Among authors: houtenbos i. Handb Exp Pharmacol. 2009;(188):319-48. doi: 10.1007/978-3-540-71029-5_15. Handb Exp Pharmacol. 2009. PMID: 19031033 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters